Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis (2019)
- Authors:
- Autor USP: ULIANA, SILVIA RENI BORTOLIN - ICB
- Unidade: ICB
- DOI: 10.1016/j.ijpddr.2019.06.003
- Subjects: PARASITOLOGIA; LEISHMANIOSE CUTÂNEA ANIMAL; FARMACOCINÉTICA; ADJUVANTES IMUNOLÓGICOS; IMUNOPARASITOLOGIA; FÁRMACOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal for Parasitology: Drugs and Drug Resistance
- ISSN: 2211-3207
- Volume/Número/Paginação/Ano: v. 11, p. 106-117, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CARIDHA, Diana et al. Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis. International Journal for Parasitology: Drugs and Drug Resistance, v. 11, p. 106-117, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ijpddr.2019.06.003. Acesso em: 22 fev. 2026. -
APA
Caridha, D., Vesely, B., Bocxlaer, K. van, Arana, B., Mowbray, C. E., Rafati, S., et al. (2019). Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis. International Journal for Parasitology: Drugs and Drug Resistance, 11, 106-117. doi:10.1016/j.ijpddr.2019.06.003 -
NLM
Caridha D, Vesely B, Bocxlaer K van, Arana B, Mowbray CE, Rafati S, Uliana SRB, Reguera R, Deitrick MK, Sciotti R, Buffet P, Croft SL. Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis [Internet]. International Journal for Parasitology: Drugs and Drug Resistance. 2019 ; 11 106-117.[citado 2026 fev. 22 ] Available from: https://doi.org/10.1016/j.ijpddr.2019.06.003 -
Vancouver
Caridha D, Vesely B, Bocxlaer K van, Arana B, Mowbray CE, Rafati S, Uliana SRB, Reguera R, Deitrick MK, Sciotti R, Buffet P, Croft SL. Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis [Internet]. International Journal for Parasitology: Drugs and Drug Resistance. 2019 ; 11 106-117.[citado 2026 fev. 22 ] Available from: https://doi.org/10.1016/j.ijpddr.2019.06.003 - Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes
- Characterization of a developmentally regulated amino acid transporter gene from Leishmania amazonensis
- Utilizacao de genes ribossomicos na identificacao de organismos do genero leishmania
- Sensitivity of Leishmania (viannia) braziliensis isolates to antimonials, amphotericin b and tamoxifen
- Antigenic polymorphism and recognition of variable domains of merozoite surface protein 1 of Plasmodium vivax (PvMSP-1) by naturally acquired antibodies of subjects from Brazilian Wester Amzonia
- In Vitro and In Vivo Miltefosine Susceptibility of a Leishmaniaamazonensis Isolate from a Patient with Diffuse CutaneousLeishmaniasis: Follow-Up
- Molecular and functional characterization of a gene encoding a leucine rich protein in Leishmania
- A new application to selective estrogen receptor modulators: tamoxifen and raloxifene as novel antileishmanial candidates
- Efect of efavirenz and nevirapine on the prolifaration of Trypanosoma cruzi epimastigotes
- The meta 2 gene: genomic comparison in trypanosomatids and characterization of the meta 2 protein of Leishmania (L.) Amazonensis
Informações sobre o DOI: 10.1016/j.ijpddr.2019.06.003 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Route map for the discove... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
